Translational control of Ybx1 expression regulates cardiac function in response to pressure overload in vivo

Eshita Varma1,2, Jana Burghaus1,2, Thomas Schwarzl3

  • 1Department of Internal Medicine III (Cardiology, Angiology, and Pneumology), Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.

PubMed

Insights

Heart failure involves RNA-binding proteins. Mechanistic target of rapamycin kinase (mTORC1) signaling activates Y-box binding protein 1 (Ybx1), driving pathological growth by increasing protein synthesis via Eef2.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • RNA Biology

Background:

  • RNA-protein interactions are crucial for heart function.
  • Regulation of RNA-binding proteins by signaling in heart failure is poorly understood.
  • Mechanistic target of rapamycin kinase (mTOR) regulates translation in cardiomyocytes.

Purpose of the Study:

  • Investigate the link between mTOR signaling and RNA-binding proteins in heart failure.
  • Determine the role of Y-box binding protein 1 (Ybx1) in pathological cardiac remodeling.
  • Elucidate the molecular mechanisms by which Ybx1 regulates cardiomyocyte growth and protein synthesis.

Main Methods:

  • Integrative transcriptome and translatome analysis.
  • Identification of messenger RNAs (mRNAs) bound by Ybx1.
  • In vivo Ybx1 depletion studies in a cardiac hypertrophy model.

Main Results:

  • mTORC1 signaling upregulates Ybx1 translation, independent of mRNA levels, during early pathological remodeling.
  • Ybx1 is essential for pathological cardiomyocyte growth by regulating protein synthesis.
  • Ybx1 binds and upregulates the translation of eukaryotic elongation factor 2 (Eef2) mRNA, promoting global protein translation and pathological growth.
  • Ybx1 depletion preserves cardiac function during pathological cardiac hypertrophy.

Conclusions:

  • mTORC1 activation links pathological signaling to altered gene expression via Ybx1.
  • Ybx1 promotes pathological cardiac hypertrophy by increasing Eef2 translation and global protein synthesis.
  • Targeting the mTORC1-Ybx1-Eef2 axis may offer therapeutic strategies for heart failure.